Financial statements Myderm Laboratories

Balance sheet of Myderm Laboratories

Company age:
Age:
9 y. 7 m. 19 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of MYDERM LABORATORIES

Year
2018
2019
2020
2021
2022
2023
Total assets 456 415,38 504 379,70 610 646,30 646 508,60 738 295,64 19 950,43
A. Fixed assets 37 964,03 28 793,15 23 252,27 17 831,39 12 410,51 -
B. Current assets 418 451,35 475 586,55 587 394,03 628 677,21 725 885,13 19 950,43
C. Share capital contributions (basic funds) - - - - - -
D. Own shares (stocks) - - - - - -
Total liabilities 456 415,38 504 379,70 610 646,30 646 508,60 738 295,64 19 950,43
A. Equity 399 230,72 442 837,56 502 354,51 611 524,83 687 027,82 -14 016,21
B. Liabilities and provisions for liabilities 57 184,66 61 542,14 108 291,79 34 983,77 51 267,82 33 966,64
I. Long-term liabilities - - - - - -
II. Short-term liabilities - - - - - -
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.